Disturbance of sensory filtering in dementia with Lewy bodies: comparison with Parkinson's disease dementia and Alzheimer's disease

Perriol, M-P.; Dujardin, K.; Derambure, P.; Marcq, A.; Bourriez, J-L.; Laureau, E.; Pasquier, F.; Defebvre, L.; Destée, A.
January 2005
Journal of Neurology, Neurosurgery & Psychiatry;Jan2005, Vol. 76 Issue 1, p106
Academic Journal
Introduction: Prepulse inhibition (PPI) is considered to mirror an organism's ability to filter out irrelevant sensory or cognitive information. The disruption of PPI has never been studied in individuals suffering from dementia with Lewy bodies (DLB). As attention deficits largely contribute to cognitive impairment in DLB, an investigation with a PPI paradigm is useful for differential diagnosis of DLB versus Alzheimer's disease (AD) and Parkinson's disease dementia (PDD).Objective and Methods: PPI of the N1/P2 component of auditory evoked potentials was used to investigate the early stages of attention selectivity in 10 DLB, 10 AD, and 10 PDD patients, as well as in 10 healthy controls. The PPI paradigm consisted of the presentation of sound pulses (40 ms, 115 dB) preceded by a prepulse (40 ms, 80 dB). Sound stimuli were presented in a total of 80 trials in a pseudo-random order. Results: Non-parametric analyses of variance revealed a significant group effect on the 120 ms lead interval. Retrospective analyses revealed that PPI was significantly reduced in DLB compared to healthy controls and AD. In the PDD group, the disturbance was of intermediate intensity. Conclusion: The present study revealed a severe disturbance of PPI in DLB patients. The DLB patients displayed a specific disruption profile in terms of magnitude as well as time course.


Related Articles

  • The role of levodopa in the management of dementia with Lewy bodies. Molloy, S.; McKeith, I. G.; O'Brien, J. T.; Burn, D. J. // Journal of Neurology, Neurosurgery & Psychiatry;Sep2005, Vol. 76 Issue 9, p1200 

    Background: One of the core clinical features of dementia with Lewy bodies (DLB) is extrapyramidal syndrome (EPS). Levodopa is currently the gold standard oral therapy for Parkinson's disease (PD), but its use in DLB has been tempered by concerns of exacerbating neuropsychiatric...

  • Influence of pre-existing dementia on the risk of post-stroke epileptic seizures. Cordonnier, C.; Hénon, H.; Derambure, P.; Pasquier, F.; Leys, D. // Journal of Neurology, Neurosurgery & Psychiatry;Dec2005, Vol. 76 Issue 12, p1649 

    Background: Seizures occur in 10% of stroke patients, but their predictors have not been clearly identified. Pre-existing dementia is present in 12-16% of stroke patients and, at the community level, patients with dementia have increased risk of seizures. However, the question of whether...

  • Factors associated with drug–induced visual hallucinations in Parkinson's disease. Papapetropoulos, Spiridon; Argyriou, Andreas A.; Ellul, John // Journal of Neurology;Oct2005, Vol. 252 Issue 10, p1223 

    Aims Visual hallucinations are common in medication-treated Parkinson's disease (PD) patients. Although their etiology is unknown several factors seem to be involved in their pathogenesis. The aim of this study was to identify possible risk factors and determine clinical characteristics...

  • Behavior Problems in a Family Member with Dementia: What You Should Know.  // American Family Physician;2/15/2006, Vol. 73 Issue 4, p653 

    Provides information on behavior problems in a family member with dementia. Problems of people with dementia; How the problems may be treated.

  • The best of times. Wallis, Lynne // Nursing Standard;8/27/2008, Vol. 22 Issue 51, p20 

    Reminiscence therapy is a popular way to engage people with dementia, but there is little evidence of its efficacy. Researchers are carrying out a randomised controlled trial of reminiscence therapy for people with dementia to ascertain its effects on patients and carers.

  • Long-Term Care Residents With Dementia. Hopper, Tammy // ASHA Leader;10/19/2004, Vol. 9 Issue 19, p10 

    Focuses on the long term care residents with a diagnosis of dementia. Mental deterioration of a woman; Assessment of the clinician; Implementation of the intervention created by the clinician.

  • older people Call for a new strategy to deal with UK's dementia timebomb. Samuel, Mithran // Community Care;3/1/2007, Issue 1662, p36 

    The article emphasizes the need for the British government to have a new strategy to deal with dementia. It notes that over 680,000 individuals have the condition, increasing to more than 1.7 million by 2051. It says that 36 percent of those with dementia live in residential care. Symptoms of...

  • Phenotype variability in progranulin mutation carriers: a clinical, neuropsychological, imaging and genetic study. Isabelle Le Ber; Agnès Camuzat; Didier Hannequin; Florence Pasquier; Eric Guedj; Anne Rovelet-Lecrux; Valérie Hahn-Barma; Julie van der Zee; Fabienne Clot; Serge Bakchine; Michèle Puel; Mustapha Ghanim; Lucette Lacomblez; Jacqueline Mikol; Vincent Deramecourt; Pascal Lejeune; Vincent de la Sayette; Serge Belliard; Martine Vercelletto; Christian Meyrignac // Brain: A Journal of Neurology;Mar2008, Vol. 131 Issue 3, p732 

    Frontotemporal dementia (FTD), characterized by behavioural and language disorders, is a clinically, genetically and pathologically heterogeneous group of diseases. The most recently identified of the four known genes is GRN, associated with 17q-linked FTD with ubiquitin-immunoreactive...

  • MAKING UP FOR LOST TIMES. Winchester, Ruth // Community Care;5/1/2003, Issue 1470, p32 

    Provides information on British citizens with dementia. Definition of dementia; Diagnosis and treatment; Measures being taken by the government to address the problem. INSETS: 'YOU HAVE TO FIGHT EVERY STEP OF THE WAY';'HEALTH AND SOCIAL CARE DISTINCTION IS MEANINGLESS'.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics